Renaissance Technologies’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Renaissance Technologies’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-571,100	Closed	-$24.2M	–	4074
2024 Q1	$24.2M	Sell	571,100 -8,300	-1%	-$351K	0.04%	551
2023 Q4	$24.2M	Sell	579,400 -9,400	-2%	-$393K	0.04%	545
2023 Q3	$22.2M	Sell	588,800 -6,100	-1%	-$230K	0.04%	526
2023 Q2	$22.6M	Sell	594,900 -4,500	-0.8%	-$171K	0.03%	622
2023 Q1	$14.6M	Sell	599,400 -12,400	-2%	-$302K	0.02%	885
2022 Q4	$17.8M	Sell	611,800 -35,100	-5%	-$1.02M	0.02%	769
2022 Q3	$19.4M	Sell	646,900 -37,400	-5%	-$1.12M	0.03%	690
2022 Q2	$24.7M	Buy	684,300 +6,000	+0.9%	+$217K	0.03%	628
2022 Q1	$29.3M	Sell	678,300 -17,700	-3%	-$766K	0.03%	552
2021 Q4	$34.9M	Sell	696,000 -24,500	-3%	-$1.23M	0.04%	448
2021 Q3	$45.8M	Sell	720,500 -16,900	-2%	-$1.08M	0.06%	338
2021 Q2	$53.1M	Sell	737,400 -15,700	-2%	-$1.13M	0.07%	304
2021 Q1	$55.5M	Sell	753,100 -32,000	-4%	-$2.36M	0.07%	312
2020 Q4	$57.6M	Buy	785,100 +16,500	+2%	+$1.21M	0.06%	302
2020 Q3	$42.2M	Buy	768,600 +35,000	+5%	+$1.92M	0.04%	437
2020 Q2	$48.8M	Buy	733,600 +67,600	+10%	+$4.49M	0.04%	435
2020 Q1	$40.8M	Buy	666,000 +49,600	+8%	+$3.04M	0.04%	452
2019 Q4	$54.2M	Buy	616,400 +34,700	+6%	+$3.05M	0.04%	494
2019 Q3	$43.9M	Buy	581,700 +28,736	+5%	+$2.17M	0.04%	550
2019 Q2	$47.2M	Buy	552,964 +126,164	+30%	+$10.8M	0.04%	517
2019 Q1	$46.1M	Buy	426,800 +46,500	+12%	+$5.03M	0.04%	551
2018 Q4	$32.2M	Buy	380,300 +49,300	+15%	+$4.17M	0.04%	624
2018 Q3	$32.5M	Buy	331,000 +44,000	+15%	+$4.33M	0.03%	650
2018 Q2	$33.2M	Buy	287,000 +25,600	+10%	+$2.96M	0.04%	627
2018 Q1	$25.8M	Buy	261,400 +8,700	+3%	+$859K	0.03%	787
2017 Q4	$26.5M	Sell	252,700 -12,600	-5%	-$1.32M	0.03%	771
2017 Q3	$29.9M	Sell	265,300 -5,466	-2%	-$616K	0.04%	664
2017 Q2	$30.3M	Sell	270,766 -35,434	-12%	-$3.97M	0.04%	617
2017 Q1	$35.7M	Sell	306,200 -241,400	-44%	-$28.2M	0.05%	488
2016 Q4	$57.6M	Sell	547,600 -82,300	-13%	-$8.66M	0.09%	271
2016 Q3	$69.6M	Buy	629,900 +9,000	+1%	+$995K	0.12%	175
2016 Q2	$90.4M	Buy	620,900 +129,600	+26%	+$18.9M	0.17%	90
2016 Q1	$70.4M	Buy	491,300 +40,100	+9%	+$5.74M	0.13%	149
2015 Q4	$69.7M	Buy	451,200 +25,600	+6%	+$3.96M	0.15%	122
2015 Q3	$60.8M	Buy	425,600 +9,000	+2%	+$1.29M	0.15%	121
2015 Q2	$59.9M	Buy	416,600 +7,994	+2%	+$1.15M	0.14%	137
2015 Q1	$57.6M	Buy	408,606 +5,106	+1%	+$720K	0.12%	169
2014 Q4	$59.8M	Buy	403,500 +6,390	+2%	+$947K	0.14%	138
2014 Q3	$61.1M	Buy	397,110 +25,910	+7%	+$3.99M	0.17%	108
2014 Q2	$52.1M	Buy	371,200 +102,800	+38%	+$14.4M	0.12%	182
2014 Q1	$29.8M	Buy	268,400 +32,927	+14%	+$3.65M	0.07%	319
2013 Q4	$23.3M	Buy	235,473 +22,373	+10%	+$2.21M	0.06%	420
2013 Q3	$16.2M	Buy	213,100 +49,900	+31%	+$3.79M	0.04%	566
2013 Q2	$9.12M	Buy	+163,200	New	+$9.12M	0.02%	788